December 6th, 2024
Paper published: Poly(vinyl alcohol) Potentiating an Inert D-Amino Acid-Based Drug for Boron Neutron Capture Therapy
The paper titled “Poly(vinyl alcohol) potentiating an inert D-amino acid-based ……
Information
November 20th, 2024
Paper published: Research on Combination of Proton Beam Therapy and Boron Nuclear Capture Reaction
The Paper titled “Increased cell killing effect in neutron capture enhanced pro……
September 6th, 2024
Conclusion of an Agreement with the National Cancer Center, Sumitomo Heavy Industries, Ltd. and CICS, Inc. for Clinical Trial of BNCT
Stella Pharma announces that it has signed an agreement with the National Cance……
August 30th, 2024
Paper published: Research on Combination Therapy of BNCT and Immune Checkpoint Inhibitors
The Paper “Overcoming immunotherapy resistance and inducing abscopal effects wi……
August 30th, 2024
Application for Orphan Drug Designation: Borofalan (10B) for Recurrent Malignant Glioma and Recurrent Meningioma
Stella Pharma announces that it has applied to the Japanese Ministry of Health,……
The paper “Efficacy and safety of boron neutron capture therapy for Hypopharyng……
June 21st, 2024
Treatment results of unresectable, locally recurrent or locally advanced head and neck cancer published
A paper containing the treatment results of unresectable, locally recurrent or ……
December 25th, 2023
Orphan Drug designation for Borofalan (10B) (SPM-011) as treatment of Cutaneous Angiosarcoma
Angiosarcoma is a kind of cancer that is derived from vascular endothelial cell……
December 6th, 2023
Encounter with Director of Cancer Research Center of Lyon, and Team of Centre Léon Bérard at French Embassy
Business France Japan Office of the French Embassy in Japan engages in building……
On 25th September, the Groundbreaking Ceremony for the Boao BNCT center has tak……
September 27th, 2022
Stella Pharma Presented at Side Events of the 66th IAEA General Conference
The 66th International Atomic Energy Agency (IAEA) General Conference is being ……
April 7th, 2022
Stella Pharma Corporation was nominated as a finalist of the Informa Pharma Intelligence Awards Japan 2022
Informa Pharma Intelligence has announced that Stella Pharma is a nominee f……
